Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2567)	8/28/2009 1:52:00 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

IMMU had a good spike yesterday after it announced results from UCB's phase IIb comparing epratuzumab to placebo in patients with SLE The data from the 12-week dose in 227 patients, showed a 'combined index endpoint advantage' of epratuzumab over placebo of 24.9% <g> The volume yesterday of 29,042,700 was > 30x its ADV and the stock is trying to hold above the $6 level as it seems it doesn't want to close much of yesterday's UG.<g> The near term UT started in early May from the $1 level.<g> bigcharts.marketwatch.com IMMU doesn't have significant LTD and according to the data on YHOO, it has +CF and +LFCF The cost of the epratuzumab Ps are been carried out by UCB.<g> The stock traded yesterday above its Apr20, 2007 H of $6.12 and the May 31-Jun30, 2004 double top at the $6.24 level. When it can close above yesterday's intraday H of $7.16, the next resistance will be the Nov2003 H at $8.70 and then the Sep2003 H at $9.70 The Mar2002 H at $21 seems to far away at present.<g> (An even more, the Feb2000 H of $40.50 <g> ) bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2567)	9/10/2009 12:53:17 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

TPI is getting ready to make another all time H.<g> It is trying again to close above the resistance at the $4 level, (it has already traded today at $4.13). Volume is still below its ADV. bigcharts.marketwatch.com It announced today that it has 4 products included in China's Essential Drug List, as released by the Chinese government on August 18. The four generic products are Azithromycin Dispersible Tablets, Simvastatin Tablets, Hugan Tablets and Xiao Yan Li Dan Capsules and Tablets. It has also scheduled a presentation by two of its directors at the Rodman & Renshaw Annual Global Investment Conference,in NY tomorrow morning.They will be discussing TPI's diversified product portfolio, customer base,recent financial results, and will also provide additional details on the $126B government sponsored healthcare reform plan and its potential benefits to TPI's long-term growth strategy. I think I will still keep my 'target' at $5 <g> bigcharts.marketwatch.com Bernard